This was a randomized controlled pilot study of Lactobacillus rhamnosus GG versus standard of care to prevent gastrointestinal multidrug-resistant organism colonization in intensive care unit patients. Among 70 subjects, there were no significant differences in acquisition or loss of any multidrug-resistant organisms (P>.05) and no probiotic-associated adverse events.

Original languageEnglish
Pages (from-to)1451-1454
Number of pages4
JournalInfection Control and Hospital Epidemiology
Issue number12
StatePublished - 2015


Dive into the research topics of 'Randomized controlled trial to determine the impact of probiotic administration on colonization with multidrug-resistant organisms in critically ill patients'. Together they form a unique fingerprint.

Cite this